Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · S

S. 1548 (117th)

ENACT Act of 2021

referredUnited States· United States Congress· EN

Introduced

11 May 2021

Last action

11 May 2021 · Introduced

Status

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsors

Sen. Luján, Ben Ray [D-NM], Sen. Collins, Susan M. [R-ME], Sen. Bennet, Michael F. [D-CO], Sen. Casey, Robert P., Jr. [D-PA], Sen. Sinema, Kyrsten [I-AZ], Sen. Moran, Jerry [R-KS], Sen. Stabenow, Debbie [D-MI], Sen. Smith, Tina [D-MN], Sen. Boozman, John [R-AR], Sen. Cassidy, Bill [R-LA], Sen. Markey, Edward J. [D-MA], Sen. Peters, Gary C. [D-MI], Sen. Wicker, Roger F. [R-MS], Sen. Capito, Shelley Moore [R-WV], Sen. Inhofe, James M. [R-OK], Sen. Murkowski, Lisa [R-AK], Sen. Booker, Cory A. [D-NJ], Sen. Hickenlooper, John W. [D-CO], Sen. Kelly, Mark [D-AZ]

Subjects

Healthcare

Source updated

5 December 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Equity in Neuroscience and Alzheimer's Clinical Trials Act of 2021 or the ENACT Act of 2021 This bill sets out activities and requirements to increase the participation of underrepresented populations in research and clinical trials for Alzheimer's disease and related dementias. Specifically, the National Institute on Aging (NIA) must establish and provide technical assistance to Alzheimer's research centers located in areas with higher concentrations of minority groups. These centers must establish diagnostic and treatment clinics designed to serve minority, rural, and other underserved populations; operate clinical trials; and carry out public outreach to encourage members of minority populations to participate in clinical trials and research. Additionally, the NIA must disseminate information to members of minority populations about participating in clinical trials and take other actions to enhance diversity with respect to the Alzheimer's research that it conducts or supports. The bill also directs the NIA to increase diversity among Alzheimer's researchers by encouraging the participation of individuals who are from groups that are underrepresented in clinical, behavioral, and social sciences.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 11 May 2021

    Introduced

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Source: IntroReferral

  2. 11 May 2021

    Introduced

    Introduced in Senate

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in Senate (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate (text)

    Introduced in Senate · EN · 11 May 2021

    ViewDownloadOpen at official source

  • Introduced in Senate (PDF)

    Introduced in Senate · EN · 11 May 2021

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate

    summary · EN · 11 May 2021

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.